Search - tctmd.com

Displaying 201 - 220 of 421

Sort: Relevancy | Date

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Presentation TCT 2014

There Is Hope for Producing Preclinical Models for Successful Device Development

Presenter: Gregory J. Wilson

September 13, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

Presentation TCT 2014

Affirmative: Time to Move On!

Presenter: Sanjay Kaul, Ajay J. Kirtane, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Presenter: Sanjay Kaul, Ajay J. Kirtane, David E. Kandzari

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

Presentation

PCI vs CABG in Patients with End-Stage Renal Disease Requiring Dialysis

Presenter: Akira Marui

June 20, 2014

Presentation

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Presenter: Murray D. Esler

June 10, 2014

Presentation EuroPCR 2014

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

May 22, 2014

Presentation

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Presenter: A. Persue

May 12, 2014

$Renal Denervation for Hypertension Refractory to Renal Artery Stenting$

Presentation

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

Presenter: Yvonne Bausback

May 02, 2014

Presentation

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Presenter: Gregg W. Stone

April 28, 2014

Presentation Fellows 2014

Renal Artery Intervention and Denervation for Resistant Hypertension

Presenter: Duane Pinto

April 14, 2014

Presentation

Preprocedural Bioimpedance Vectorial Analysis (BIVA) of Fluid Status and Prediction of Contrast-Induced AKI

Presenter: 232162|Mauro Maioli

February 11, 2014

Presentation

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Presenter: Fabrizio Tomai

January 07, 2014

Presentation

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Presenter: Ziad Hijazi

December 23, 2013

Presentation

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Presenter: E. Perdoncin

December 10, 2013

Presentation

Why is there So Much Excitement Over Renal Denervation?

Presenter: Michael R. Jaff

December 01, 2013

Presentation

What We Don’t Know, But Need to Know About Renal Denervation

Presenter: Krishna Rocha-Singh

December 01, 2013

Advertisement

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

There Is Hope for Producing Preclinical Models for Successful Device Development

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Affirmative: Time to Move On!

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

PCI vs CABG in Patients with End-Stage Renal Disease Requiring Dialysis

Catheter-Based Renal Denervation for Treatment of Patients with Treatment-Resistant Hypertension

Predictors of nonresponse to renal denervation in a real world population of patients with uncontrolled hypertension: Analysis of the Global SYMPLICITY Registry

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

Renal Denervation for Hypertension Refractory to Renal Artery Stenting

ACC 2014 Late Breaking Trials Renal Denervation for Resistant Hypertension

Renal Artery Intervention and Denervation for Resistant Hypertension

Preprocedural Bioimpedance Vectorial Analysis (BIVA) of Fluid Status and Prediction of Contrast-Induced AKI

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Why is there So Much Excitement Over Renal Denervation?

What We Don’t Know, But Need to Know About Renal Denervation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content